Intermittent fasting and metabolic dysfunction-associated steatotic liver disease: the potential role of the gut-liver axis
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern linked to the increasing prevalence of metabolic syndrome, including obesity and type 2 diabetes (T2D). MASLD remains a significant clinical challenge due to th... ...
